Hadassah Hebrew University Medical Center
Hadassah Hebrew University Medical Center
Jerusalem, Israel2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2026-05-27 | NCT06225596 | |
| Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, Osteopenia, bone disorder, metabolic disease, musculoskeletal system disorder | Recruiting | Phase 4 | 2025-09-18 | NCT06762730 |